Population Council Contraception Development Research Center Administrative Core

行政核心--摘要 人口理事会(PC)P50避孕发展研究中心将召集产品专家 开发(包括设计、配方、制造和测试)、社会行为科学和临床科学， 和监管事务内的PC和我们的学术合作伙伴，以推动我们的多功能发展 预防技术(MPT)阴道内环(IVR)，简称CZL-IVR，以满足女性的需求 在全球范围内，通过提供非荷尔蒙避孕和性传播感染/艾滋病毒预防以及优化阴道健康。 行政核心(AC)将是P50中心的核心，提供科学、执行和 行政领导、资源分配和影响研究优先事项。管理委员会将担任 主要的后勤、监督和运营推动者，确保P50中心顺利运作。交流电 将与我们的外部和社区咨询委员会一起实施年度战略规划进程，包括 持续审查和必要的调整，促进P50项目之间的协作团队合作， 并对项目和P50中心的日常工作提供整体支持。咨询委员会将通过以下方式确保我们的科学的严谨性 提供监管监督和支持以及数据管理和统计专业知识。此外， 咨询委员会将提供培训机会和试点拨款，以支持青年科学家和早期科学家 研究人员发展以避孕和性传播感染/艾滋病毒预防为重点的职业。咨询委员会将利用 其多学科专家团队的广泛技能、知识和专业知识，以及数十年的成功 在PC生物医学研究中心(CBR)开发避孕产品，以建立P50中心 并支持其活动，以促进我们创新的非激素MPT CZL-IVR。

ADMINISTRATIVE CORE – ABSTRACT The Population Council (PC) P50 Contraception Development Research Center will convene experts in product development (including design, formulation, manufacture, and testing), social-behavioral and clinical science, and regulatory affairs within PC and our academic partners to advance the development our multipurpose prevention technology (MPT) intravaginal ring (IVR), referred to as the CZL-IVR, to meet the needs of women globally by providing non-hormonal contraception and STI/HIV prevention as well as optimizing vaginal health. The Administrative Core (AC) will be at the heart of the P50 Center, providing scientific, executive, and administrative leadership, allocating resources, and influencing research priorities. The AC will serve as the primary logistical, supervisory, and operational driver, ensuring smooth functioning of the P50 Center. The AC will implement an annual strategic planning process with our external and community advisory committees, with ongoing review and adjustments as necessary, promotion of collaborative teamwork across the P50 projects, and day-to-day support of the projects and P50 Center overall. The AC will ensure rigor of our science by providing regulatory oversight and support as well as data management and statistical expertise. Furthermore, the AC will provide training opportunities and pilot grant funding to support young scientists and early stage investigators developing careers focusing on contraception and STI/HIV prevention. The AC will leverage the extensive skills, knowledge, and expertise of its multidisciplinary team of experts and the decades of successful contraceptive product development at PC’s Center of Biomedical Research (CBR) to establish the P50 Center and support its activities in order to advance our innovative non-hormonal MPT CZL-IVR.